IMMUNOLOGICAL responses appear to be involved in limiting the extent of some human tumours, and stimulation of this immune response is currently being investi-(fated as a treatment for cancer, both as adjuvant therapy following radical surgery and in advanced disease. Levamisole, Bacille Calmette-Guerin and Corynebacterium parvum are all known to stimulate various components of the immune response, and C. parrum given i.v. inhibits primary tumour growth and metastasis formation in experimental animal tumours (Castro, 1977) . The level of immunity is heightened by this treatment, as demonstrated by delayed hypersensitivity testing (Israel et al., . However, i.v. injection of bacteria and bacterial products also activat,es blood coagulation and fibrinolysis (Sherry et al., 1959a, b) and there is evidence that tumour growth and implantation of cancer cells may be impeded by anticoacgulation or activation of fibrinolysis (Peterson, 1968; Rudenstam, 1968; Brown, 1973 Venous blood samples were drawn with minimal or no venous occlusion through a butterfly needle inserted in the opposite arm to that used for injection of the organism. The first few ml of blood were discarded, and then 7 ml was drawn into a polystyrene syringe for 3-thromboglobul.in estimation (Radiochemical Centre, Amersham). Blood for the remaining tests was drawn into a polypropylene syringe. A full blood count, (Coulter S) platelet count (Technicon Autocounter) and examination of a film, were performed on blood anticoagulated with EDTA, and the remaining blood was anticoagulated with a one-tenth (Hardisty and Ingram, 1965) fibrinogen by the method of Burmester et al. (1970) and ethanol gel according to Godal and Abildgaard (1966) .
Plasma fibrinolytic activity was measured by diluting 0 5 ml plasma containing a trace of 1251-labelled fibrinogen with 4*5 ml 0.9% NaCl. This was then clotted with 10 u bovine thrombin, the clots enmeshed on crushed glass and incubated at 22°C for 60 min. After centrifuging, the clots were washed with 2 10 ml volumes of saline and the radioactivity remaining in the clot was expressed as a percentage of the total radioactivity in the original plasma. The mean incorporation of radioactivity in untreated controls was 62% (n = 10) and this was regarded as the baseline fibrinolytic activity for the patients.
Plasminogen-activator activity was measured in euglobulin fractions on bovine fibrin plates (Astrup and Mullertz, 1952) .
Other euglobulin fractions prepared from plasma containing 1251-labelled fibrinogen were redissolved in an original volume of barbitone buffer, clotted with 2-5 u of bovine thrombin and incubated for exactly 60 min at 370C. The remaining clot was removed and the radioactivity measured in both clot and supernatant fluid. The proportion of fibrin lysed at 60 min was then determined.
Plasminogen, oU2-macroglobulin, X1-antitrypsin and antithrombin III were measured by radial immunodiffusion on plates obtained from Hoechst Pharmaceuticals (Hoechst House, Kew Bridge, Brentford, Middlesex). Antiplasmin activity was measured by an adaptation of the gel-diffusion method of Lane et al. (1975) .
There was a large fall in the number of white blood cells, with the virtual disappearance of lymphocytes. There was also a slight decrease in the platelet count and the 3-thromboglobulin levels increased (Table) .
Factor VIII antigen level started to increase 80 min after the start of infusion, and was more than 31 x the baseline level in the 250 min samples. There was a corresponding but smaller increase in Factor VIII procoagulant activity over the same period (Fig. 1) . Although there was a slight shortening of the kaolin/cephalin time, the prothrombin time, thrombin time, fibrinogen concentration, ethanol gelation, antithrombin III, plasminogen, ao2-macroglobulin and ocl-antitrypsin concentrations did not change.
Both dilute plasma (Fig. 2a) and the euglobulin fraction (Fig. 2b) showed a marked increase in fibrinolytic activity at 140 min, but both returned to baseline values by 250 min after the start of the infusion. There was a corresponding fall in antiplasmin activity, and the formation of high levels of fibrin(ogen) degradation products.
The in vitro addition of C. parvum to anticoagulated whole blood, plasma or euglobulin fraction produced no change in any of the above tests.
The injection of C. parvum induces a severe disturbance of homeostasis, which could be detected shortly after completion of the infusion. There was a rapid rise in temperature, often with a period of hypotension and peripheral vasoconstriction. Fever persists for some hours but the hypotension and vasoconstriction are relatively short-lived. With such a severe physiological disturbance it would be expected that various cellular and metabolic functions would be altered. Most attention has been paid to changes in immunological function (Gill et at., 1977; Castro, 1977) but we have demonstrated marked activation of the fibrinolytic mechanism, with evidence of plasminogen activator release as well as increased lysis of fibrin(ogen). This stimulation appears to be rapidly controlled, for at 250 min most variables have returned to normal. This activation of fibrinolysis is presumably responsible for the large increase in fibrin-(ogen) degradation products that occurs at 140 min, even though there was no detectable change in fibrinogen concentration.
The changes in Factor VIII levels appear to follow a completely different time course. Factor VIII procoagulant activity and Factor VIII antigen levels were still rising at 250 min, when fibrinolytic activity had returned to normal. It is not clear from these results whether the changes in fibrinolysis are directly related to activation of the clotting system, and further investigation is required to elucidate this point.
The time lag from the infusion of the organism to the development of fibrinolytic activity probably permits the release of a substance or substances which then induce the physiological and haematological changes. White cells may release proteases or plasminogen activators (Gans, 1964) and this would result in an increase in fibrinolytic activity. Furthermore, the overall response to infusion of C. parvum is similar to the response seen after endotoxin infusion, which can bring about intravascular clotting, fibrinolytic activation and endothelial damage (McKay, 1966; Horwitz et al., 1972) although C. parvum is not a Gram-negative organism which releases lipopolysaccharide endotoxins.
Alterations in coagulation and fibrinolysis can produce profound effects on the growth and spread of experimental animal tumours (Peterson, 1968; Rudenstam, 1968; Brown, 1973) and there is some evidence that this may be of therapeutic benefit in man (Hughes, 1964) . Activation of fibrinolysis is associated with a reduction in the numbers of metastases which develop from experimental primary tumours (Cliffton and Agostino, 1962) . Such a response might be of therapeutic importance in our own trial, where the primary tumour has been removed. Repeated activation of fibrinolytic activity might prevent implantation of circulating micrometastases, whilst alteration in the haemostatic balance might be the explanation for the beneficial effects that were seen following daily i.v. injections of C. parvum in patients with advanced malignancy (Israel et al., 1975) . If this were so, the use of direct fibrinolytic stimulators might be indicated.
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